Feedback / Questions
LX2006 - Lexeo Therap
https://www.globenewswire.com/news-release/2024/04/16/2863488/0/en/Lexeo-Therapeutics-Granted-FDA-Fast-Track-Designation-for-LX2006-an-AAV-Based-Gene-Therapy-Candidate-for-the-Treatment-of-Friedreich-s-Ataxia-Cardiomyopathy.html
Apr 16, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next